MiCo BioMed Co., Ltd. (KOSDAQ:214610)
South Korea flag South Korea · Delayed Price · Currency is KRW
499.00
-4.00 (-0.80%)
At close: Apr 4, 2025, 3:30 PM KST

MiCo BioMed Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
25,69760,85380,68187,860166,501204,207
Upgrade
Market Cap Growth
-24.58%-24.58%-8.17%-47.23%-18.46%148.32%
Upgrade
Enterprise Value
33,33173,659100,38997,164156,031213,436
Upgrade
Last Close Price
499.001397.001852.003081.225841.477221.60
Upgrade
PS Ratio
4.6913.1215.035.455.504.47
Upgrade
PB Ratio
0.842.352.224.983.193.65
Upgrade
P/TBV Ratio
3.143.142.615.323.273.71
Upgrade
EV/Sales Ratio
7.1815.8718.706.035.154.67
Upgrade
EV/EBITDA Ratio
----40.72
Upgrade
EV/EBIT Ratio
----61.59
Upgrade
Debt / Equity Ratio
0.830.830.381.320.420.12
Upgrade
Debt / EBITDA Ratio
-----1.28
Upgrade
Asset Turnover
0.080.080.090.220.380.95
Upgrade
Inventory Turnover
1.171.170.850.920.822.03
Upgrade
Quick Ratio
1.091.091.420.574.023.93
Upgrade
Current Ratio
1.891.892.701.335.946.46
Upgrade
Return on Equity (ROE)
-90.33%-90.33%-95.59%-111.40%-19.57%-20.29%
Upgrade
Return on Assets (ROA)
-23.72%-23.72%-21.02%-22.17%-8.50%4.51%
Upgrade
Return on Capital (ROIC)
-28.23%-28.23%-27.48%-28.10%-9.90%5.24%
Upgrade
Return on Capital Employed (ROCE)
-----5.60%
Upgrade
Earnings Yield
-120.05%-50.69%-31.95%-44.27%-6.35%-2.83%
Upgrade
FCF Yield
-45.34%-19.15%-14.56%-17.79%-6.87%-11.97%
Upgrade
Buyback Yield / Dilution
-76.40%-76.40%-12.65%-0.19%-25.24%-22.97%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.